[引用][C] 378 A first-in-human (FIH) safety and pharmacological study of SAR405838, a novel HDM2 antagonist, in patients with solid malignancies

V De Weger, MP Lolkema, M Dickson… - European Journal of …, 2014 - infona.pl
378 A first-in-human (FIH) safety and pharmacological study of SAR405838, a novel HDM2
antagonist, in patients with solid malignancies × Close The Infona portal uses cookies, ie …
被引用次数：13 相关文章